Developer docs
API playgroundTry for free, no card

Search company profiles

Creadev

Full company profile

uuid000738b

Namestring
Creadev
Legal namestring
CREADEV
Websiteurl
creadev.com
Company typeenum
Private
Founded yearint
2002
Descriptiontext

Creadev is a private, evergreen investment company founded in 2002 by the Mulliez family, the French entrepreneurial dynasty behind retail brands including Décathlon, Leroy Merlin, Auchan, and Kiabi. The firm finances and supports growth-stage SMEs (revenue above €10M in Europe, $20M in the US) across three verticalized sectors — Health (8 portfolio companies, €600M deployed), Food (14 companies, €450M), and Climate (4 companies, €60M) — with initial ticket sizes of €10–30M and an objective of helping portfolio companies reach €100M in revenue within five years. It operates from offices in Paris, Lille, New York, and Nairobi, deploying up to €250M annually to fund 5–10 companies, and has invested approximately €2.6B to date across Europe, Africa, and the United States. As an evergreen investor without a fixed exit horizon, Creadev can hold positions long-term and offers portfolio companies the option of eventual integration into the broader Mulliez family ecosystem of 150+ companies across 62 countries.

The firm differentiates through its patient capital model, the Mulliez family network, and its values-aligned investment approach anchored in impact themes. Creadev sources deals through direct entrepreneur outreach, ecosystem referrals, and proactive scouting across its three geographies, then supports portfolio companies via governance structuring, board participation, and an operating-partner bench drawn from consulting (BCG, Bain), financial services (KPMG, Deloitte, EY, PwC, Crédit Agricole, Natixis, Bpifrance), and operators (Orange, Doctolib, IQVIA, Décathlon). Its leadership includes Benoit Legrand as President, Bertrand Boré as Directeur Général, Séverine Tapié-Mulliez on the Supervisory Board, and regional leads Pierre Fauvet (Africa, since 2017) and Joel Filippi (USA).

Creadev's revenue mechanics differ from traditional fund managers: as an evergreen family vehicle, it generates returns through capital appreciation, dividends, and exits via trade sales, IPOs, or secondary transactions rather than through management fees or carried interest. Its 2024 portfolio impact metrics — 26,400 tonnes of CO2 avoided, 7,192 tonnes of wild fish fishing avoided, 367,000 people treated, and 306 million meals served — illustrate the operational scale of the underlying portfolio and the firm's impact-investment positioning.

Short descriptiontext

Creadev is a privately held, evergreen investment firm founded in 2002 by the Mulliez family, financing growth-stage SMEs in health, food, and climate across Europe, Africa, and the United States with up to €250M deployed annually.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
51–100
akta.pro rankint
HeadquartersParis, France
HQ citystring
Paris
HQ countrystring
France
HQ regionstring
Europe
Markets served

Serves global market

Offices4 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
private equity investment, growth equity capital, impact investing, evergreen fund, family office investing
Product category
Private Equity / Growth Equity Investing
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Capital gains and investment returns
TypeLicensing Royalties
Description

Creadev generates returns through equity investments in growth-stage companies. As an evergreen investor without a fixed exit horizon, it holds positions long-term and exits through trade sales, IPOs, or secondary transactions. The firm benefits from capital appreciation and dividend distributions from portfolio companies.

creadev.com
Marketing channels3 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels2 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components4 values
Personnel, Operations, Marketing or Sales, Others
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

Creadev is an evergreen growth equity investment company that deploys up to €250M per year into 5–10 high-potential SMEs with positive impact in three verticals: Health, Food/Agri-food, and Climate transition. Initial tickets typically range €10–30M, targeting European companies with revenue above €10M or US companies above $20M, with a stated objective of helping them reach €100M revenue within five years. In addition to capital, Creadev provides governance structuring, strategic support, and access to the Mulliez family ecosystem of 150+ companies and 615,000 collaborators.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 4 values shown
  • Portfolio companies have avoided 26,400 tonnes of CO2 emissions in 2024
+3 more records
Product overview1 text field

Creadev is an evergreen investment company founded in 2002 by the Mulliez family (Decathlon, Leroy Merlin, Auchan). The company offers investment services across three core verticals: Food (14 companies, €450M invested), Santé/Health (8 companies, €600M invested), and Climat/Climate (4 companies, €60M invested). Creadev operates through regional offices in Europe (Paris, Lille), Africa (Nairobi), and the USA (New York), deploying up to €250 million annually to accelerate 5-10 positive-impact companies. Investment typically ranges €10-30M with a goal of helping companies reach €100M revenue within 5 years. The company leverages the Mulliez family ecosystem of over 150 enterprises and 615,000 collaborators to provide portfolio companies with networks, expertise, and long-term capital.

Product and service2 records
1Creadev Evergreen Growth Equity Investment Services
CategoryGrowth Equity / Private Equity
Description

Evergreen growth equity investment service deploying up to €250M annually into 5–10 high-growth SMEs with proven business models across Europe, Africa, and the United States. Initial investments typically range €10–30M, targeting European companies with revenue above €10M or US companies above $20M, with a stated goal of helping portfolio companies reach €100M revenue within five years.

2Santé (Health) Investment Vertical
Scale indicator7 records

Each record includes

Type, Value, Description, Source

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Long-standing French listed investment firm with evergreen family-controlled origins, now diversified across industrials, healthcare, and services. Comparable in patient capital approach, French family heritage, and long-dated holding structure.

TypeRegional player
Description

Belgian-listed European private equity and venture firm with strong focus on health, food/consumer, and sustainable cities. Comparable sector overlap and mid-cap growth equity approach, though primary focus is the Benelux/European market.

TypeBroad incumbent
Description

France's public investment bank providing growth equity, venture, and debt financing to French SMEs. Directly comparable in its €100M+ revenue scaling mission (Bpifrance Large Venture) and health/tech sector focus; competitor for many of Creadev's deals.

TypeDirect peer
Description

Leading French private equity firm with a strong growth equity and venture arm, investing across healthcare, food/consumer, and climate. Eurazeo is the closest pure comparable to Creadev in terms of size, French heritage, and sector coverage.

5Ardian
TypeDirect peer
Description

Paris-based global private investment house with significant growth equity, venture, and direct lending capabilities. Comparable to Creadev in evergreen patient capital philosophy, multi-sector mandate, and French roots.

TypeDirect peer
Description

Independent French private equity firm with growth and venture strategies including dedicated health and climate impact funds. Comparable in size, French origin, and focus on mid-cap growth equity in similar sectors to Creadev.

TypeEmerging player
Description

French impact-focused private equity and venture firm. Highly comparable to Creadev in its mission-driven approach and focus on food, health, and climate; some of Creadev's team alumni (e.g., Maud Lehman) previously worked at Raise Impact.

TypeDirect peer
Description

Belgian family-controlled evergreen investment company with a long-term capital approach analogous to Creadev's Mulliez family model. Operates as a long-only patient investor across diversified sectors.

TypeDirect peer
Description

Paris-based alternative asset manager with growth equity, private debt, and impact investing strategies. Similar in size, French origin, and focus on health, food, and climate transitions to Creadev.

TypeEmerging player
Description

French agro-industrial group with a private equity arm historically active in food and agricultural value chains. Highly comparable in food sector focus; some Creadev senior team alumni (e.g., Bénédicte Monpert) worked at Sofiprotéol.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat6 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers11 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles22 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A1 record

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment50 records

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Creadev

Private Equity / Growth Equity Investingcreadev.com

Creadev is a privately held, evergreen investment firm founded in 2002 by the Mulliez family, financing growth-stage SMEs in health, food, and climate across Europe, Africa, and the United States with up to €250M deployed annually.

What Creadev does

Creadev is a private, evergreen investment company founded in 2002 by the Mulliez family, the French entrepreneurial dynasty behind retail brands including Décathlon, Leroy Merlin, Auchan, and Kiabi. The firm finances and supports growth-stage SMEs (revenue above €10M in Europe, $20M in the US) across three verticalized sectors — Health (8 portfolio companies, €600M deployed), Food (14 companies, €450M), and Climate (4 companies, €60M) — with initial ticket sizes of €10–30M and an objective of helping portfolio companies reach €100M in revenue within five years. It operates from offices in Paris, Lille, New York, and Nairobi, deploying up to €250M annually to fund 5–10 companies, and has invested approximately €2.6B to date across Europe, Africa, and the United States. As an evergreen investor without a fixed exit horizon, Creadev can hold positions long-term and offers portfolio companies the option of eventual integration into the broader Mulliez family ecosystem of 150+ companies across 62 countries.

The firm differentiates through its patient capital model, the Mulliez family network, and its values-aligned investment approach anchored in impact themes. Creadev sources deals through direct entrepreneur outreach, ecosystem referrals, and proactive scouting across its three geographies, then supports portfolio companies via governance structuring, board participation, and an operating-partner bench drawn from consulting (BCG, Bain), financial services (KPMG, Deloitte, EY, PwC, Crédit Agricole, Natixis, Bpifrance), and operators (Orange, Doctolib, IQVIA, Décathlon). Its leadership includes Benoit Legrand as President, Bertrand Boré as Directeur Général, Séverine Tapié-Mulliez on the Supervisory Board, and regional leads Pierre Fauvet (Africa, since 2017) and Joel Filippi (USA).

Creadev's revenue mechanics differ from traditional fund managers: as an evergreen family vehicle, it generates returns through capital appreciation, dividends, and exits via trade sales, IPOs, or secondary transactions rather than through management fees or carried interest. Its 2024 portfolio impact metrics — 26,400 tonnes of CO2 avoided, 7,192 tonnes of wild fish fishing avoided, 367,000 people treated, and 306 million meals served — illustrate the operational scale of the underlying portfolio and the firm's impact-investment positioning.

Creadev firmographics

Firmographics
Name
Creadev
Legal name
CREADEV
Website
https://creadev.com
Company type
Private
Founded year
2002
Operating status
Operating
Headcount range
51–100 employees
Short description
Creadev is a privately held, evergreen investment firm founded in 2002 by the Mulliez family, financing growth-stage SMEs in health, food, and climate across Europe, Africa, and the United States with up to €250M deployed annually.
Ownership category
akta.pro rank

Where Creadev is headquartered

Location

Headquarters

HQ city
Paris
HQ country
France
HQ region
Europe

Offices4 records

Markets served

Creadev business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Marketing or Sales, Others

Revenue model

  1. Capital gains and investment returns: Creadev generates returns through equity investments in growth-stage companies. As an evergreen investor without a fixed exit horizon, it holds positions long-term and exits through trade sales, IPOs, or secondary transactions. The firm benefits from capital appreciation and dividend distributions from portfolio companies.

Go-to-market motion1 record

Distribution channels2 records

Marketing channels3 records

Creadev product offering

Product offering

Core offering

Creadev is an evergreen growth equity investment company that deploys up to €250M per year into 5–10 high-potential SMEs with positive impact in three verticals: Health, Food/Agri-food, and Climate transition. Initial tickets typically range €10–30M, targeting European companies with revenue above €10M or US companies above $20M, with a stated objective of helping them reach €100M revenue within five years. In addition to capital, Creadev provides governance structuring, strategic support, and access to the Mulliez family ecosystem of 150+ companies and 615,000 collaborators.

Product overview

Creadev is an evergreen investment company founded in 2002 by the Mulliez family (Decathlon, Leroy Merlin, Auchan). The company offers investment services across three core verticals: Food (14 companies, €450M invested), Santé/Health (8 companies, €600M invested), and Climat/Climate (4 companies, €60M invested). Creadev operates through regional offices in Europe (Paris, Lille), Africa (Nairobi), and the USA (New York), deploying up to €250 million annually to accelerate 5-10 positive-impact companies. Investment typically ranges €10-30M with a goal of helping companies reach €100M revenue within 5 years. The company leverages the Mulliez family ecosystem of over 150 enterprises and 615,000 collaborators to provide portfolio companies with networks, expertise, and long-term capital.

Differentiator

Problem solved

Functional benefit

Products and services

  • Creadev Evergreen Growth Equity Investment Services Evergreen growth equity investment service deploying up to €250M annually into 5–10 high-growth SMEs with proven business models across Europe, Africa, and the United States. Initial investments typically range €10–30M, targeting European companies with revenue above €10M or US companies above $20M, with a stated goal of helping portfolio companies reach €100M revenue within five years.
  • Santé (Health) Investment Vertical

Quantifiable outcome

  • Portfolio companies have avoided 26,400 tonnes of CO2 emissions in 2024
  • +3 more outcomes

Companies that use Creadev

Customer profile

Named customers11 records

Segments3 records

Ideal customer profiles3 records

Creadev technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Creadev partnerships and signals

Strategic signal

Scale indicators7 records

Recent moves6 records

Expansion highlights5 records

Creadev competitors and assessment

Company assessment

Direct peers

  • Wendel: Long-standing French listed investment firm with evergreen family-controlled origins, now diversified across industrials, healthcare, and services. Comparable in patient capital approach, French family heritage, and long-dated holding structure.
  • Eurazeo: Leading French private equity firm with a strong growth equity and venture arm, investing across healthcare, food/consumer, and climate. Eurazeo is the closest pure comparable to Creadev in terms of size, French heritage, and sector coverage.
  • Ardian: Paris-based global private investment house with significant growth equity, venture, and direct lending capabilities. Comparable to Creadev in evergreen patient capital philosophy, multi-sector mandate, and French roots.
  • LBO France: Independent French private equity firm with growth and venture strategies including dedicated health and climate impact funds. Comparable in size, French origin, and focus on mid-cap growth equity in similar sectors to Creadev.
  • Compagnie Nationale à Portefeuille (CNP): Belgian family-controlled evergreen investment company with a long-term capital approach analogous to Creadev's Mulliez family model. Operates as a long-only patient investor across diversified sectors.
  • Tikehau Capital: Paris-based alternative asset manager with growth equity, private debt, and impact investing strategies. Similar in size, French origin, and focus on health, food, and climate transitions to Creadev.

Regional players

  • Gimv: Belgian-listed European private equity and venture firm with strong focus on health, food/consumer, and sustainable cities. Comparable sector overlap and mid-cap growth equity approach, though primary focus is the Benelux/European market.

Broad incumbents

  • Bpifrance: France's public investment bank providing growth equity, venture, and debt financing to French SMEs. Directly comparable in its €100M+ revenue scaling mission (Bpifrance Large Venture) and health/tech sector focus; competitor for many of Creadev's deals.

Emerging players

  • Raise Impact: French impact-focused private equity and venture firm. Highly comparable to Creadev in its mission-driven approach and focus on food, health, and climate; some of Creadev's team alumni (e.g., Maud Lehman) previously worked at Raise Impact.
  • Sofiprotéol / Groupe Avril: French agro-industrial group with a private equity arm historically active in food and agricultural value chains. Highly comparable in food sector focus; some Creadev senior team alumni (e.g., Bénédicte Monpert) worked at Sofiprotéol.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat6 records

Key risks6 records

Key highlights6 records

Customer concentration

Creadev social profiles

Digital presence

Creadev financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Creadev leadership team

Management profile

Number of profiles

Profiles22 records

Creadev funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Creadev M&A and investment

M&A and investment

M&A1 record

Investments50 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Creadev

What does Creadev do?

Creadev is an evergreen growth equity investment company that deploys up to €250M per year into 5–10 high-potential SMEs with positive impact in three verticals: Health, Food/Agri-food, and Climate transition. Initial tickets typically range €10–30M, targeting European companies with revenue above €10M or US companies above $20M, with a stated objective of helping them reach €100M revenue within five years. In addition to capital, Creadev provides governance structuring, strategic support, and access to the Mulliez family ecosystem of 150+ companies and 615,000 collaborators.

Is Creadev a public or private company?

Creadev is a private company. It is classified as family owned and is currently operating.

When was Creadev founded?

Creadev was founded in 2002. It employs 51 to 100 people.

Where is Creadev based?

Creadev is headquartered in Paris, France, in the Europe region.

How does Creadev make money?

One revenue line is on record: capital gains and investment returns.

Who are Creadev's main competitors?

Direct peers on record are Wendel, Eurazeo, Ardian, LBO France, Compagnie Nationale à Portefeuille (CNP) and Tikehau Capital. Gimv is listed as a regional player. Bpifrance is listed as a broad incumbent. Emerging players are Raise Impact and Sofiprotéol / Groupe Avril.

Does Creadev have an API?

No public API is recorded for Creadev.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
TechweezTwiga Foods Placed Under Administration Over Financial TroublesGT Flow Limited, formerly Twiga Foods One, was placed under statutory administration in Kenya on August 17, with Mohamed Mohamed appointed administrator. The company, which raised $185.4 million, faces a 30-day window for creditors to submit claims. A separate liquidation petition was filed against Twiga Tatu SEZ.PR NewswireInsect Feed Market Accelerates Sustainable Protein Transition as Alternative Feed Demand Surges | CAGR 15.4% | Persistence Market ResearchThe global insect feed market is projected to grow from $3.1 billion in 2026 to $8.4 billion by 2033, a CAGR of 15.4%. Europe holds 31% of the market, with Black Soldier Fly larvae leading at 46% share. Innovafeed raised €51 million to scale its Black Soldier Fly production.PR NewswireInsect Feed Market Accelerates Sustainable Protein Transition as Alternative Feed Demand Surges | CAGR 15.4% | Persistence Market ResearchThe global insect feed market is projected to grow from $3.1 billion in 2026 to $8.4 billion by 2033, a CAGR of 15.4%. Black Soldier Fly larvae lead with 46% share, and Europe holds 31% of the market. Innovafeed raised €51 million to scale its Black Soldier Fly production.CapitalСтартъп новини | Фураж от насекоми; Сателити на 200 км от Земята; Дом от пластмасаInnovafeed raised €51M from existing investors and banks, scaling production tenfold since 2022. NewOrbit raised €16M in Series A to build a satellite production complex opening in 2027. Both funds target expansion in aquaculture and low-Earth orbit satellite manufacturing.FinSMEsInnovafeed Raises €51M in FundingInnovafeed, a Paris-based insect-based ingredient developer, raised €51M from Creadev, Qatar Investment Authority, Temasek, and others. The funds will accelerate commercial development of its Hilucia product lines and invest in processing equipment. The company has scaled output tenfold at its Nesle facility, producing over 15,000 tons of oils and proteins.The French Tech Journal🇫🇷 French Tech Funding Wire June 8: Paris No. 8; Quobly €115M Led 8 Deals for €200.7MEight French tech startups raised €200.7M in funding, led by Quobly's €115M Series A for quantum computing. The round includes Innovafeed's €51M growth equity and Innovorder's €20M. Paris remains the top hub, with over 21,000 startups and 42 unicorns.FRENCHWEB.FRINNOVAFEED lève 51 millions d’euros tout en supprimant 60 postes : le paradoxe de l’industrialisationInnovafeed raised 51 million euros from historical investors while planning to cut about 60 jobs, two-thirds at its Gouzeaucourt site. The company claims to have produced over 15,000 tonnes of insect proteins and oils, with costs divided by seven. Funds will accelerate commercialization of its Hilucia™ range and new applications.MaddynessInnovafeed lève 51 millions d’euros, mais supprime une soixantaine de postesInnovafeed raised 51 million euros from investors to accelerate commercial growth and expand its Nesle factory. The funding comes with a plan to cut about 60 jobs, including its Gouzeaucourt R&D site. The company expects 13.5 million euros in revenue by year-end and aims for profitability within two years.Les EchosDamae Medical obtient 15 M€ auprès de CreadevDamae Medical secured €15 million in equity funding during its Series B round, led by Creadev, the investment firm of the Mulliez family. Creadev's investment exceeded €10 million, representing the lower end of its typical investment range for such rounds. Marc Chipot, senior investment director at Creadev, highlighted the firm's evergreen status as enabling long-term commitment to companies demonstrating strong potential to become sector leaders.